Ling Rui Pharmaceutical disclosed its semi-annual report on August 11. The company achieved operating income of 2,148 billion yuan in the first half of the year, an increase of 2.32%; net profit attributable to shareholders of listed companies of 495 million yuan, an increase of 4.36% over the previous year; and basic earnings per share of 0.874 yuan/share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.